SCHEMBL7303949

SCHEMBL7303949

CCCCCCC(=O)Nc1cccc(-n2nnnc2S)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.48
POLB P06746 1/20 0.48
HDAC3 O15379 5/20 0.47
HDAC1 Q13547 5/20 0.47
HDAC2 Q92769 5/20 0.47
HDAC10 Q969S8 5/20 0.47
HDAC8 Q9BY41 5/20 0.47
HDAC6 Q9UBN7 5/20 0.47
RAB9A P51151 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
NPC1 O15118 1/20 0.46
SOAT2 O75908 3/20 0.46
SOAT1 P35610 3/20 0.46
ALDH1A1 P00352 2/20 0.46
CRHBP P24387 1/20 0.46
CRHR2 Q13324 1/20 0.46
MAPT P10636 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
USP2 O75604 1/20 0.45
HPGD P15428 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6571817 1.00 LMNA (0.48) LMNAPOLBHDAC3HDAC1HDAC2
SCHEMBL10349031 1.00 LMNA (0.48) LMNAPOLBHDAC3HDAC1HDAC2
SCHEMBL9769971 1.00 LMNA (0.48) LMNAPOLBHDAC3HDAC1HDAC2
SCHEMBL8059281 1.00 LMNA (0.48) LMNAPOLBHDAC3HDAC1HDAC2
SCHEMBL14498627 1.00 LMNA (0.48) LMNAPOLBHDAC3HDAC1HDAC2
SCHEMBL9769968 1.00 LMNA (0.48) LMNAPOLBHDAC3HDAC1HDAC2
SCHEMBL5154079 0.99 LMNA (0.47) LMNAPOLBHDAC3HDAC1HDAC2
SCHEMBL14498628 0.96 SMN1; SMN2 (0.49) LMNAHDAC3HDAC1HDAC2HDAC10
SCHEMBL9769965 0.91 ALDH1A1 (0.48) LMNARAB9AALDH1A1CRHBPCRHR2
SCHEMBL10468788 0.87 LMNA (0.48) LMNAPOLBHDAC3HDAC1HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5874432-A Saccharin derivatives useful as proteolytic enzyme inhibitors and compositions and method of use thereof SANOFI (FR) 1999-02-23 US disclosed
EP-0471756-B1 SACCHARIN DERIVATIVES USEFUL AS PROTEOLYTIC ENZYME INHIBITORS AND PREPARATION THEREOF SANOFI SA (FR) 1997-10-29 EP disclosed
US-5650422-A TREATMENT OF EMPHYSEMA, ARTHRITIS OR PANCREATITIS SANOFI (FR) 1997-07-22 US disclosed
US-5596012-A Saccharin derivatives useful as proteolytic enzyme inhibitors and compositions and method of use thereof STERLING WINTHROP INC. (US) 1997-01-21 US disclosed
US-5371074-A Use of saccharin derivatives as proteolytic enzyme inhibitors STERLING WINTHROP INC. (US) 1994-12-06 US disclosed
US-5236917-A Respiratory system disorders, antiarthritic agents STERLING WINTHROP INC. (US) 1993-08-17 US disclosed
EP-0542372-A1 2-Substituted saccharin derivative proteolytic enzyme inhibitors STERLING WINTHROP INC. (US) 1993-05-19 EP disclosed
WO-1990013549-A1 SACCHARIN DERIVATIVES USEFUL AS PROTEOLYTIC ENZYME INHIBITORS AND PREPARATION THEREOF STERLING WINTHROP INC. (US) 1990-11-15 WO disclosed